Fallopian Tube News and Research

RSS
Genentech's OCEANS Phase III study of Avastin in platinum-sensitive ovarian cancer meets primary endpoint

Genentech's OCEANS Phase III study of Avastin in platinum-sensitive ovarian cancer meets primary endpoint

NCI sponsors fourth REOLYSIN clinical trial in pancreatic cancer

NCI sponsors fourth REOLYSIN clinical trial in pancreatic cancer

How chlamydia increases risk of ectopic pregnancy

How chlamydia increases risk of ectopic pregnancy

Ovarian cancer tissue and healthy tissue smell different

Ovarian cancer tissue and healthy tissue smell different

Oncolytics initiates enrollment in Phase II ovarian cancer study

Oncolytics initiates enrollment in Phase II ovarian cancer study

Exelixis reports interim data from phase 2 RDT trial for epithelial ovarian cancer

Exelixis reports interim data from phase 2 RDT trial for epithelial ovarian cancer

Oregon scientist investigates safety, effectiveness of novel low-cost family-planning option

Oregon scientist investigates safety, effectiveness of novel low-cost family-planning option

Synta reports $10.3M net loss for third quarter 2010 vs. $118.1M net income for third quarter 2009

Synta reports $10.3M net loss for third quarter 2010 vs. $118.1M net income for third quarter 2009

Novel serum test may help diagnose early pregnancy location and outcome

Novel serum test may help diagnose early pregnancy location and outcome

GOG to initiate combination elesclomol-paclitaxel Phase 2 clinical trial for ovarian cancer

GOG to initiate combination elesclomol-paclitaxel Phase 2 clinical trial for ovarian cancer

Research suggests bevacizumab delays progression in newly diagnosed ovarian cancer

Research suggests bevacizumab delays progression in newly diagnosed ovarian cancer

Phase-II clinical trial of MLN8237 drug shows promising results for treating ovarian cancer

Phase-II clinical trial of MLN8237 drug shows promising results for treating ovarian cancer

Spirogen, Celtic Therapeutics announces initiation of Phase II ovarian cancer trial with SG2000

Spirogen, Celtic Therapeutics announces initiation of Phase II ovarian cancer trial with SG2000

Researchers investigate human reovirus with chemotherapy for ovarian cancer

Researchers investigate human reovirus with chemotherapy for ovarian cancer

BC gynecologists initiate campaign to reduce ovarian cancer mortality

BC gynecologists initiate campaign to reduce ovarian cancer mortality

Preventive surgery protects against breast, ovarian cancer in women carrying BRCA1, BRCA2 gene mutations

Preventive surgery protects against breast, ovarian cancer in women carrying BRCA1, BRCA2 gene mutations

GOG to conduct Phase II trial on primary peritoneal cancer

GOG to conduct Phase II trial on primary peritoneal cancer

Genentech's second Phase III ICON7 study of Avastin in ovarian cancer meets primary endpoint

Genentech's second Phase III ICON7 study of Avastin in ovarian cancer meets primary endpoint

Combination of reovirus and carboplatin/paclitaxel shows promising anticancer activity in SCCHN

Combination of reovirus and carboplatin/paclitaxel shows promising anticancer activity in SCCHN

Genentech to present new data for targeted cancer medicines at 46th ASCO

Genentech to present new data for targeted cancer medicines at 46th ASCO